Vericel Corporation

(VCEL) Trade

By |

Profile

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

Contact Information

Website: www.vcel.com
Email: ir@vcel.com
Main Phone: +1 800 556-0311
Address: 64 Sidney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NSC
CEO: Dominick Colangelo
Employees: 216
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

Contact Information

Website: www.vcel.com
Email: ir@vcel.com
Main Phone: +1 800 556-0311
Address: 64 Sidney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NSC
CEO: Dominick Colangelo
Employees: 216
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 15.95 $ -0.05 (-0.31%)
Last Price 15.95 Change $ -0.05 Change % -0.31 Tick N/A
Bid 15.94 Bid Size 100.00 Ask 15.97 Ask Size 200.00
Open 16.03 High 16.09 Low 15.81 Prev Close 16.00
Last Trade Volume 266,625 52 Wk Hi 21.01 52 Wk Low 10.51
Market Cap 704 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 44,136,896.00 EPS (TTM) -0.40 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 29 31
Number of Buys 9 11
Number of Sells 20 20
Net Activity 35541 69644
Last 10 Buys Shares
Alan L. Rubino 1,000
Alan L. Rubino 1,000
Alan L. Rubino 1,000
Daniel Orlando 1,000
Dominick Colangelo 1,000
Gerard J. Michel 1,000
Ronald Cresswell 1,000
Scott Durbin 1,000
Scott Durbin 1,000
Timothy Mayleben 1,000
Last 10 Sell Shares
Dominick Colangelo 1,000
Dominick Colangelo 1,000
Dominick Colangelo 1,000
Dominick Colangelo 1,000
Dominick Colangelo 1,000
Daniel Orlando 1,000
Daniel Orlando 1,000
Daniel Orlando 1,000
Daniel Orlando 1,000
Daniel Orlando 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17.5 15 15 17.5
Low Target Price Estimate 13 13 13 13
Mean Target Price Estimate 14.88 14.25 14.25 14.88
Standard Deviation 1.93 0.96 0.96 1.93
Date of Most Recent Estimate 06/04/18 05/08/18 05/08/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 2
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.6 1.6 1.6 1.75